Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
09/12/2013 | US20130237561 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
09/12/2013 | US20130236550 Pharmaceutical microparticles |
09/12/2013 | US20130236544 Stable pharmaceutical compositions of fesoterodine |
09/12/2013 | US20130236534 Modified drugs for use in liposomal nanoparticles |
09/12/2013 | US20130236514 Pharmaceutical Compositions Comprising Terbinafine |
09/12/2013 | US20130236513 Synthetic Polyurethane Composite |
09/12/2013 | US20130236505 Production Of Pharmaceutical Protective Coatings With Good Resistance In A Neutral Environment |
09/12/2013 | US20130236500 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same |
09/12/2013 | US20130236461 Antibodies that bind il-4 and/or il-13 and their uses |
09/12/2013 | US20130236434 Agonists that enhance binding of integrin-expressing cells to integrin receptors |
09/12/2013 | US20130236401 Process for the preparation of inverse latex of acrylamide-based polymers and composition comprising said latex |
09/12/2013 | US20130236396 Nanoparticles produced from recombinant polymers and methods of making and using the same |
09/11/2013 | EP2636749A1 Non-reducing end-modified glucan, method for producing same, and use thereof |
09/11/2013 | EP2636748A1 Amino sugar-containing glucan, method for producing same and use of same |
09/11/2013 | EP2636739A1 iRNA agents targeting VEGF |
09/11/2013 | EP2636684A1 Prevention of infection |
09/11/2013 | EP2636408A1 Patch |
09/11/2013 | EP2636405A1 Felbinac-containing external patch |
09/11/2013 | EP2636403A1 Production of pharmaceutical protective overalls with good resistance in a neutral environment |
09/11/2013 | EP2635632A1 Compressible, highly viscous polysaccharide and polyol powder |
09/11/2013 | EP2635585A1 High-efficiency catalysts, preparation and use thereof |
09/11/2013 | EP2635310A2 Engineered polypeptide conjugates and methods for making thereof using transglutaminase |
09/11/2013 | EP2635309A2 Anti-diabetic compounds |
09/11/2013 | EP2635308A2 Compositions of a peptide targeting system for treating cancer |
09/11/2013 | EP2635307A2 Pharmaceutical compositions |
09/11/2013 | EP2635300A1 Dock-and-lock (dnl) constructs for human immunodeficiency virus (hiv) therapy |
09/11/2013 | EP2635287A1 Administration of nedd8-activating enzyme inhibitor |
09/11/2013 | EP2635273A2 Isoflavonoid compositions and methods for the treatment of cancer |
09/11/2013 | EP2635269A1 A combination composition |
09/11/2013 | EP2635262A2 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles |
09/11/2013 | EP2635260A2 Compositions and methods for the delivery of therapeutics |
09/11/2013 | EP2635254A1 Compositions and methods relating to reduced mucoadhesion |
09/11/2013 | EP2635121A1 Isoflavonoid compounds and methods for the treatment of cancer |
09/11/2013 | EP2319517B1 Use of prodrugs for ocular intravitreous administration |
09/11/2013 | CN103298947A Amino sugar-containing glucan, method for producing same and use of same |
09/11/2013 | CN103298946A Method for utilizing monoterpene glycosyltransferase |
09/11/2013 | CN103298926A 干细胞悬浮液 Stem cell suspensions |
09/11/2013 | CN103298451A Brimonidine gel compositions and methods of use |
09/11/2013 | CN103298443A Oil-in-water emulsion composition |
09/11/2013 | CN103293316A A method of diagnosis and treatment |
09/11/2013 | CN103290695A Method for one-step realization of water stability treatment and functional modification of gamma-PGA nano fiber |
09/11/2013 | CN103290018A Nucleic acid aptamer specifically bound with human epidermal growth factor receptor III-type mutant and application of nucleic acid aptamer |
09/11/2013 | CN103290017A HER2 (Human Epidermal Growth Factor Receptor 2) protein nucleotide aptamer, complex composition and applications thereof |
09/11/2013 | CN103289107A Preparation method and application of injectable silk fibroin in-situ gel |
09/11/2013 | CN103289103A Self-assembling method of glucose-containing thermosensitive copolymer |
09/11/2013 | CN103289100A Polyethylene glycol-polyamide-amine-hydrophobic molecular linear-dendritic polymer and preparation method thereof |
09/11/2013 | CN103289097A Pluronic-modified PAMAM (polyamide-amine) graft polymer and application |
09/11/2013 | CN103289082A Block copolymer and preparation method thereof |
09/11/2013 | CN103289078A Method for rapidly preparing polyamino acid and derivative thereof and application of method |
09/11/2013 | CN103289077A Acid-catalyzed hydrolysis difunctionalized alkyl silyl ether and preparation method thereof |
09/11/2013 | CN103289075A Conjugate of polyethylene glycol and naloxone, and pharmaceutical composition and applications thereof |
09/11/2013 | CN103289008A Gel particles based on alkyl silicon ether and preparation method of gel particles |
09/11/2013 | CN103288967A Establishment and expression of fusion protein having function of adsorbing heavy metal ions, and application fusion protein in bioremediation |
09/11/2013 | CN103288957A Antibody drug derivative inhibiting tumor growth, its preparation method and use |
09/11/2013 | CN103288949A Interferon alpha mutant and polyethylene glycol derivative thereof |
09/11/2013 | CN103288948A Interferon alpha mutant and polyethylene glycol derivative thereof |
09/11/2013 | CN103288947A Interferon alpha mutant and polyethylene glycol derivative thereof |
09/11/2013 | CN103285411A Preparation method of poly(lactic-co-glycolic acid based magnetic medicine-carrying hollow microspheres |
09/11/2013 | CN103285407A Preparation method of polyamide-amine type dendritic macromolecule-entrapped miR-21 gene inhibitor |
09/11/2013 | CN103285403A Sugar-containing porphyrin complexation photosensitizer and preparation method thereof |
09/11/2013 | CN103285402A New application of polyethylene glycol and pigment epithelium derived growth factor conjugate |
09/11/2013 | CN103285401A Composition capable of improving solubility and bioavailability of insoluble medicament |
09/11/2013 | CN103285400A Acid sensitive polymer prodrug, nanoparticles of prodrug and application of nanoparticles |
09/11/2013 | CN103285399A Freezing and drying protecting agent for amyxis brucella live vaccine |
09/11/2013 | CN103285395A Combinations and modes of administration of therapeutic agents and combination therapy |
09/11/2013 | CN103285393A Egg yolk antibody microcapsule for resisting hand-foot-and-mouth disease, and preparation method thereof |
09/11/2013 | CN103285383A Pharmaceutical composition comprising bromelain and bromelain enteric-coated tablet |
09/11/2013 | CN103285375A Phycocyanin microsphere preparation and preparation method thereof |
09/11/2013 | CN103285371A Antibacterial peptide stable preparation and preparation method thereof |
09/11/2013 | CN103285176A Micro-powder granules for treating fever disease of pigs and preparation process thereof |
09/11/2013 | CN103285137A Donkey-hide-gelatin-containing instant granules and preparation method thereof |
09/11/2013 | CN103285036A Colla corii asini dispersible tablet and preparation method thereof |
09/11/2013 | CN103285035A Medicine for treating dry skin chilblain and manufacturing method thereof |
09/11/2013 | CN103285002A Compound norfloxacin double-layered suppository for animals, and preparation method thereof |
09/11/2013 | CN103284996A Vagina swelling metronidazole clotrimazole suppository and preparation method and detection method thereof |
09/11/2013 | CN103284985A Stable (S)-alpha-methyl-4-(2-methylpropyl) phenylacetic acid medicine composition |
09/11/2013 | CN103284973A Adefovir dipivoxil composition and preparation method thereof |
09/11/2013 | CN103284972A Prescription of clopidogrel bisulfate tablet and preparation process thereof |
09/11/2013 | CN103284970A Sarpogrelate hydrochloride sustained release preparation and preparation method thereof |
09/11/2013 | CN103284969A Risperidone dispersible tablet and preparation method thereof |
09/11/2013 | CN103284968A Aripiprazole composition microcrystalline orally disintegrating tablets and preparation method thereof |
09/11/2013 | CN103284967A Steady amoxicillin dispersible tablet |
09/11/2013 | CN103284966A 坎地沙坦酯分散片 Candesartan cilexetil tablet |
09/11/2013 | CN103284965A Bioavailable solid dosage forms of metaxalone |
09/11/2013 | CN103284961A Preparing method of cobamamide freeze-drying formulation for injection |
09/11/2013 | CN103284960A Vincristine freeze-dried powder injection |
09/11/2013 | CN103284958A Cefdinir composition granule and preparation method thereof |
09/11/2013 | CN103284957A Preparation method of polylactic acid/carmustine drug carrying microsphere for malignant brain tumors |
09/11/2013 | CN103284956A Chlortetracycline premix and preparation method thereof |
09/11/2013 | CN103284955A Long-acting progestational hormone controlled-release injection implant and preparation method thereof |
09/11/2013 | CN103284953A Bicyclol solid preparation and preparation method thereof |
09/11/2013 | CN103284950A Sebum liposome and preparation method for same |
09/11/2013 | CN103284949A A kitasamycin antimicrobial nanoemulsion drug and a preparation method thereof |
09/11/2013 | CN103284948A Preparation and application of polymer composition loaded with sirolimus compound or its derivative |
09/11/2013 | CN103284944A Method for preparing long-acting terramycin injection by utilizing carbamide and sodium bisulfite in combined way |
09/11/2013 | CN103284943A Novel method for preparing penehyclidine hydrochloride injection |
09/11/2013 | CN103284942A High-permeability emulsifiable paste for diminishing inflammation and easing pain |
09/11/2013 | CN103284941A Expansion suppository of clotrimazole or salt thereof, preparation method and detection method |
09/11/2013 | CN103284158A Goose oil diacylglycerol microcapsules |
09/11/2013 | CN103284146A L-carnitine tea polyphenol tablet and preparation method thereof |